US Patent Issued to Quatssant on Oct. 28 for "Antimicrobial with modified-chitosan functionalization via dopamine linkage" (New Jersey Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,348, issued on Oct. 28, was assigned to Quatssant LLC (Monmouth Junction, N.J.).

"Antimicrobial with modified-chitosan functionalization via dopamine linkage" was invented by Randell Clevenger (North Plainfield, N.J.), Cheoljin Kim (North Brunswick, N.J.) and Kristin Blacklock (Holmdel, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition comprising a doubly conjugated chitosan polymer or oligomer, and a functionalized metal work piece including the doubly conjugated chitosan polymer or oligomer."

The patent was filed on July 20, 2022, under Application No. 17/869,064.

*For further information, including images, charts and tables, ple...